Overview

https://www.bio-itworldexpowest.com/

Pharmaceutical companies are undergoing a digital transformation. By experimenting with new initiatives, they are positioned to play a role in the revolution of healthcare. This transformation is driven by data from internal and external sources, including both -omic data and that from digital devices. Bio-IT World WEST, part of Molecular Medicine Tri-Conference, brings together all the stakeholders involved in this transformation.

https://www.arena-international.com/octwestcoast/ 

Join pharmaceutical, medical device and biotechnology experts to discuss new trends and opportunities and learn how to optimize their clinical operation knowledge and stay ahead of the game.

Find the right solution providers to partner with to accelerate your trial timelines.

The 2020 program has four dedicated streams:

• Clinical Operations & Outsourcing
• Technology & Innovation
• Patient Engagement (NEW for this editions)
• Medical Device Trials

https://aat-adpd.kenes.com/

The AAT-AD/PD™ Focus Meeting 2020 in Vienna will for a second year present all the latest breakthroughs in treatment, translational R&D, early diagnosis, drug development and clinical trials in Alzheimer’s, Parkinson’s and other related neurological disorders.

https://www.bio-itworldexpo.com/

Booth #: 525

In the spirit of open collaboration, the world’s premier bio-IT conference will bring together the community to focus on how we are using technologies and analytic approaches to solve problems, accelerate science, and drive the future of precision medicine. With a focus on AI, data science and other “data-driven” technologies that are advancing biomedical research, drug discovery and healthcare, the Bio-IT World Conference & Expo ’20 will bring together more than 3,000 participants to the Seaport World Trade Center in Boston from April 21-23.

https://www.aacr.org/Meetings/Pages/MeetingDetail.aspx?EventItemID=213&DetailItemID=1057

Booth #2241

The AACR Annual Meeting program covers the latest discoveries across the spectrum of cancer research—from population science and prevention; to cancer biology, translational, and clinical studies; to survivorship and advocacy—and highlights the work of the best minds in research and medicine from institutions all over the world.

https://www.aan.com/conferences-community/annual-meeting

The world’s best and most comprehensive neurology meeting is coming to one of the world’s most diverse and cosmopolitan cities—Toronto— April 25 to May 1, 2020, and registration is now open. The 2020 AAN Annual Meeting offers innovative, unique, and creative experiences throughout the week served up in exciting and inspirational formats to fuel your mind, body, and spirit

https://nash-summit.com/

Now in its 4th year, the NASH Summit (Boston, MA) is the industry’s most comprehensive conference for advancing the development of successful NASH candidates.

By providing an unrivaled breadth of thought-leading discussion across discovery, translational, non-invasive biomarker and clinical drug development tracks, as well as new content on clinical safety, pathological fibrosis and market access; this intimately focused discussion and networking forum has the complete agenda you need to navigate the next 12 months of NASH drug development.

https://www.arena-international.com/octeastcoast/

Booth #: 57

Discover effective strategies for outsourcing clinical trial operations to ensure studies run smoothly and within budget!

https://www.arena-international.com/octuk/

Join pharmaceutical, medical device and biotechnology experts to discuss new trends and opportunities and learn how to optimize their clinical operation knowledge and stay ahead of the game.

Find the right solution providers to partner with to accelerate your trial timelines.

The 2020 program has four dedicated streams:

• Clinical Operations & Outsourcing
• Technology & Innovation
• Patient Engagement (NEW for this editions)
• Medical Device Trials

https://meetings.asco.org/am/program

Booth #: TBD

ASCO offers premier scientific events for oncology professionals, patients, patient advocates, industry representatives, and major media outlets worldwide.

https://am.snmmi.org/imis/SNMMI-AM/Event_Details/SNMMI-AM/Event_Details.aspx?hkey=f39f72f5-d9d5-46d6-9bd1-126af59fa217

Booth #: 359

The SNMMI 2020 Annual Meeting is recognized as the premier educational, scientific, research, and networking event in nuclear medicine and molecular imaging. The four day event, taking place each June, provides physicians, technologists, pharmacists, laboratory professionals, and scientists with an in-depth view of the latest research and development in the field as well as providing insights into practical applications for the clinic.

https://nrm2020.org/

Since 1997, the NRM convenes experts in the field of neuroreceptors and serves as a platform to discuss the latest breakthroughs in quantifying neuroreceptors in the human brain using Positron Emission Tomography (PET). A wide range of methodological advances are traditionally discussed, including novel brain molecular imaging agents, pharmacokinetic analysis, radio metabolites and analytical methods are traditionally discussed in this meeting. Furthermore, the NRM includes sections devoted to neuroreceptor abnormalities in neuropsychiatric and neurological conditions with particular attention to quantification of protein aggregates in neurodegenerative conditions.

https://www.diaglobal.org/en/flagship/dia-2020/about/conference

Booth #: 1850

Fueled by the ideas of more than 7000 attendees, the DIA 2020 Global Annual Meeting will bring together patients, industry, regulators, and academia from all angles of the product lifecycle, from more than 50 countries. It’s the intersection of science, healthcare, and regulation, with no barriers, just a catalyst for thoughtful dialogue and debate.
Read more at https://www.diaglobal.org/en/flagship/dia-2020/about/conference#LiM8clVymWxZs5Bd.99

https://www.alz.org/aaic/about/overview.asp

The Alzheimer’s Association International Conference^® is the largest and most influential international meeting dedicated to advancing dementia science. Each year, AAIC^® convenes the world’s leading basic science and clinical researchers, next-generation investigators, clinicians and the care research community to share research discoveries that’ll lead to methods of prevention and treatment and improvements in the diagnosis of Alzheimer’s disease.

https://www.ecnp.eu/Congress2020/ECNPcongress

The annual ECNP Congress is Europe’s premier scientific meeting for disease-oriented brain research, attracting neuroscientists, psychiatrists and neurologists from around the world.

https://www.mdscongress.org/Congress-2020.htm

The purpose of the MDS International Congress is to share ideas, encourage interest among all those involved in the care and research of movement disorders, to participate in the activities of MDS, and to advance the related clinical and scientific discipline

https://www.arena-international.com/octnewengland/

Join pharmaceutical, medical device and biotechnology experts to discuss new trends and opportunities and learn how to optimize their clinical operation knowledge and stay ahead of the game.

Find the right solution providers to partner with to accelerate your trial timelines.

The 2020 program has four dedicated streams:

• Clinical Operations & Outsourcing
• Technology & Innovation
• Patient Engagement (NEW for this editions)
• Medical Device Trials

General Information

Booth #: TBA

With more than 150 Sessions, the EANM Annual Congress is the most valuable Nuclear Medicine Meeting worldwide.

https://www.ctad-alzheimer.com/ctad-2020

The future of clinical trials may lie in revisiting all drugs known to be safe and evaluate their relevance in AD treatment. We learned at CTAD 2019 of the importance of non-pharmaceutical trials and that anti-amyloid treatment for AD should begin early on in the disease process. We also discovered new promising treatments and we learned more of another pathway with Tau Biomarkers, and their implications for AD along with combination therapeutics and phase 3 clinical trials results. Again in 2020 Clinical teams will present their population studies on subjects in the early stage of the disease or even at the asymptomatic stage.

CTAD 2020 will highlight the latest on trying to get these trials off the ground.

Overall, the aim of the conference is to overcome the hurdles and speed the development of effective treatments.

https://www.sitcancer.org/events

Booth #: TBD

https://acnp.org/annual-meeting/

The Annual Meeting is one of the world’s leading forums for the exchange of cutting edge scientific information about the brain, behavior, and psychotropic drugs.